Showing results (71-80 of 112) with videos related to
Sort By:
Pageof 12
Gastroenterology|August 13, 2018
Combined Inactivation of TP53 and MIR34A Promotes Colorectal Cancer Development and Progression in Mice Via Increasing Levels of IL6R and PAI1Meryem Gülfem Öner, Matjaz Rokavec, Markus Kaller, et al.Cell Cycle (Georgetown, Tex.)|February 14, 2007
c-MYC delays prometaphase by direct transactivation of MAD2 and BubR1: identification of mechanisms underlying c-MYC-induced DNA damage and chromosomal instabilityAntje Menssen, Alexey Epanchintsev, Dmitri Lodygin, et al.Archives of Biochemistry and Biophysics|July 13, 2025
The immunological and prognostic landscape of TFAP4 in cancer: A single-cell RNA sequencing perspectiveLinghui Zhong, Zidong Feng, Feng Li, et al.Cell Cycle (Georgetown, Tex.)|February 23, 2007
Digital karyotyping reveals frequent inactivation of the dystrophin/DMD gene in malignant melanomaHenrike Körner, Alexey Epanchintsev, Carola Berking, et al.Cell Cycle (Georgetown, Tex.)|June 8, 2007
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrestValery Tarasov, Peter Jung, Berlinda Verdoodt, et al.Proceedings of the National Academy of Sciences of the United States of America|December 23, 2011
The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loopAntje Menssen, Per Hydbring, Karsten Kapelle, et al.Molecular & Cellular Proteomics : MCP|May 14, 2011
Genome-wide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysisMarkus Kaller, Sven-Thorsten Liffers, Silke Oeljeklaus, et al.Oncotarget|April 28, 2016
CYB5R1 links epithelial-mesenchymal transition and poor prognosis in colorectal cancerChristine Woischke, Cristina Blaj, Eva Marina Schmidt, et al.Plos One|August 12, 2014
Colorectal cancers mimic structural organization of normal colonic cryptsLaura Cernat, Cristina Blaj, Rene Jackstadt, et al.Cell Cycle (Georgetown, Tex.)|August 23, 2008
Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancerDmitri Lodygin, Valery Tarasov, Alexey Epanchintsev, et al.Pageof 12